Contrast induced exacerbation of renal dysfunction in the advanced chronic kidney disease

Cardiovascular Intervention and Therapeutics

Volumn 28, Issue 2, 2013, Pages 157-161

  Taniguchi, Yousuke ^a   Sakakura, Kenichi ^a   Wada, Hiroshi ^a   Sugawara, Yoshitaka ^a   Funayama, Hiroshi ^a   Kubo, Norifumi ^a   Momomura, Shin ichi ^a   Ako, Junya ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Anemia; Contrast induced nephropathy; Contrast media; Coronary angiography; Proteinuria

Indexed keywords

CREATININE; IOHEXOL; IOMEPROL; IOPAMIDOL; IOVERSOL;

ADULT; AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; CONTRAST INDUCED NEPHROPATHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART CATHETERIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA;

EID: 84876022259     PISSN: 18684300     EISSN: 18684297     Source Type: Journal    
DOI: 10.1007/s12928-012-0143-y     Document Type: Article

References (23)

1. Schweiger MJ, Chambers CE, Davidson CJ, Blankenship J, Bhalla NP, Block PC, et al. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures. Catheter Cardiovasc Interv. 2007; 69: 135-40.
2. Benko A, Fraser-Hill M, Magner P, Capusten B, Barrett B, Myers A, et al. Canadian Association of Radiologists: consensus guidelines for the prevention of contrast-induced nephropathy. Can Assoc Radiol J. 2007; 58: 79-87.
3. Gruberg L, Mintz GS, Mehran R, Gangas G, Lansky AJ, Kent KM, et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol. 2000; 36: 1542-8.
4. Barrett BJParfrey PS. Prevention of nephrotoxicity induced by radiocontrast agents. N Engl J Med. 1994; 331: 1449-50.
5. Chong E, Shen L, Poh KKTan HC. Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention. Singap Med J. 2012; 53: 164-9.
6. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004; 44: 1393-9.
7. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351: 1296-305.
8. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002; 105: 2259-64.
9. Caruso M, Balasus F, Incalcaterra E, Ruggieri A, Evola S, Fattouch K, et al. Contrast-induced nephropathy after percutaneous coronary intervention in simple lesions: risk factors and incidence are affected by the definition utilized. Intern Med. 2011; 50: 983-9.
10. McCullough PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F, et al. Risk prediction of contrast-induced nephropathy. Am J Cardiol. 2006; 98: 27K-36K.
11. Irie F, Iso H, Sairenchi T, Fukasawa N, Yamagishi K, Ikehara S, et al. The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. Kidney Int. 2006; 69: 1264-71.
12. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Hara S, et al. Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol. 2007; 11: 41-50.
13. IRON deficiency anaemia; report of a study group. World Health Organ Tech Rep Ser. 1959; 182: 1-15.
14. van Hove L, Schisano T, Brace L. Anemia diagnosis, classification, and monitoring using Cell-Dyn technology reviewed for the New Millennium. Lab Hematol. 2000; 6: 93-108.
15. Cerda J, Lameire N, Eggers P, Pannu N, Uchino S, Wang H, et al. Epidemiology of acute kidney injury. Clin J Am Soc Nephrol. 2008; 3: 881-6.
16. Silverberg D, Wexler D, Blum M, Wollman YIaina A. The cardio-renal anaemia syndrome: does it exist? Nephrol Dial Transplant. 2003; 18 Suppl 8: viii7-12.
17. Clark JJ, Wong LL, Lurie FKamitaki BK. Proteinuria as a predictor of renal dysfunction in trauma patients receiving intravenous contrast. Am Surg. 2011; 77: 1194-200.
18. Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA. 2010; 303: 423-9.
19. Jackson CE, Solomon SD, Gerstein HC, Zetterstrand S, Olofsson B, Michelson EL, et al. Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet. 2009; 374: 543-50.
20. Iseki K, Ikemiya Y, Iseki CTakishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int. 2003; 63: 1468-74.
21. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004; 43: S1-290.
22. Yoon HJ, Hur SH. Determination of safe contrast media dosage to estimated glomerular filtration rate ratios to avoid contrast-induced nephropathy after elective percutaneous coronary intervention. Korean Circ J. 2011; 41: 265-71.
23. Sakakura K, Wada H, Taniguchi Y, Mori M, Momomura S, Ako J. Intravascular ultrasound-guided coronary stenting without contrast meium for the treatment of catheter-induced aortocoronary dissection. Cardiovasc Interv Ther. 2012. doi: 10. 1007/s12928-012-0114-3.